Results 191 to 200 of about 120,343 (298)

Analysis of Maternal Near-miss and Mortality with Hematologic Diseases in a Single Quaternary Referral Center in Southern Thailand. [PDF]

open access: yesJ Obstet Gynaecol India
Peeyananjarassri K   +5 more
europepmc   +1 more source

KSHV/HHV8-mediated hematologic diseases.

open access: yesBlood, 2022
Cesarman E, Chadburn A, Rubinstein PG.
europepmc   +1 more source

Brain and Liver Dual‐Targeting Oridonin Nanoparticles to Enhance Aβ Clearance for Alzheimer's Disease Therapy

open access: yesAdvanced Science, EarlyView.
We developed a nanoparticle named OAF, which simultaneously targeted to both the brain and liver via the transferrin receptor 1 (TfR1) receptor, promoting lipoprotein receptor‐related protein 1 (LRP1) expression to enhance amyloid‐beta (Aβ) clearance. In AD mice model, OAF significantly reduced Aβ deposition and cognitive impairment, while a mitigating
Wenshuai Gong   +8 more
wiley   +1 more source

BCOR gene alterations in hematologic diseases.

open access: yesBlood, 2021
Sportoletti P, Sorcini D, Falini B.
europepmc   +1 more source

A Synergistic Hydrogel‐Microalgae Platform for Dual‐Targeting of Intestinal and Neuroimmune Dysfunction in Inflammatory Bowel Disease

open access: yesAdvanced Science, EarlyView.
A bioactive hydrogel incorporating Chlorella vulgaris and paeoniflorin within a carboxymethyl chitosan/sodium alginate matrix cross‐linked with genipin is developed for inflammatory bowel disease therapy. The hydrogel exhibits gastric stability and intestine‐responsive release.
Jing Lu   +8 more
wiley   +1 more source

Microglia‐Targeted Biomimetic Tetrahedral Framework Nucleic Acid Nanovesicles for Synergistic Treatment of Sepsis‐Associated Encephalopathy

open access: yesAdvanced Science, EarlyView.
Sepsis‐associated encephalopathy (SAE) lacks effective therapies. We developed ME@FDsi, a biomimetic nanodrug using a tetrahedral framework nucleic acid to deliver disulfiram and siTNFα. It crosses the blood‐brain barrier, targets M1 microglia, inhibits pyroptosis and inflammation, and scavenges ROS.
Huimin Shi   +15 more
wiley   +1 more source

Adult AML with NUP98 rearrangements should be stratified into adverse-risk group

open access: yesBlood Cancer Journal
Wusixian Huang   +6 more
doaj   +1 more source

CEBPA double mutations associated with ABO antigen weakness in hematologic diseases. [PDF]

open access: yesBlood Adv
Choi SJ   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy